ICD 10 CM M06.051 | Description & Clinical Information
ICD 10 M06.051 describes a persistent joint disease known as rheumatoid arthritis, characterized by inflammation and deformity, which is believed to be caused by an autoimmune response where antibodies react to the body’s own proteins, and in this particular case, it affects the right hip and has not been confirmed by the presence of rheumatoid factor in the blood.
Official Description Of M06.051
The ICD 10 CM book defines ICD 10 code M06.051 as:
When To Use M06.051
The diagnosis describes by ICD 10 CM M06.051 is non-rheumatoid factor (nonRF) rheumatoid arthritis of the right hip. This form of arthritis is characterized by joint inflammation, stiffness, swelling, and deformity. The affected joint may also feel warm to the touch and appear reddened. Patients may experience pain and difficulty moving their hip joint due to the inflammation, and weakness of the surrounding muscles may occur. Additionally, nodules under the skin, sleep difficulties, and fatigue are common with this condition.
To diagnose nonRF rheumatoid arthritis of the right hip, a healthcare provider will evaluate the patient’s medical history and perform a physical examination. Blood tests can help differentiate this condition from others that may have similar symptoms. Inflammatory markers such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) may be elevated in cases of rheumatoid arthritis. Presence of Rheumatoid Factor (RF), antibodies and autoantibodies can also provide insights into the specific form of arthritis that is present. To rule out gout, a urinalysis to measure uric acid levels may be performed. Analysis of the joint fluid for bacteria can also help rule out an infection as the source of the symptoms. And, X-rays can also provide information on joint damage and deformity.
There are several treatment options available for nonRF rheumatoid arthritis of the right hip. Range of motion, strength, and flexibility exercises can improve mobility and reduce pain. Diet modifications may also help with symptom management. When necessary, medication can be used to manage pain or reduce inflammation in the joint. Corticosteroids, disease-modifying antirheumatic drugs and biologic response modifiers can be effective in treating the symptoms of rheumatoid arthritis. Biologic response modifiers are a product of genetic engineering that specifically target the immune system components that cause inflammation. Finally, if joint damage is severe, surgery may be necessary to repair or replace the hip joint.
Managing nonRF rheumatoid arthritis of the right hip can require a thoughtful, comprehensive approach. There are many variables to consider when deciding on a course of treatment, and careful communication between the patient and the healthcare provider is essential to creating a successful treatment plan. By working together, patients and providers can effectively manage the symptoms of arthritis and help those with the condition to maintain a good quality of life.
